Paul Sauer - Dec 30, 2022 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
SVP Process Dev, Manufacturing
Signature
Paul Sauer, by /s/ Ron A. Metzger, Attorney-in-Fact
Stock symbol
PCVX
Transactions as of
Dec 30, 2022
Transactions value $
$0
Form type
4
Date filed
1/4/2023, 03:32 PM
Previous filing
Sep 7, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCVX Stock Option (right to buy) Award $0 +15K $0.00 15K Dec 30, 2022 Common Stock 15K $47.95 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Paul Sauer is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 1/48 of shares subject to the option vest on January 30, 2023, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date.